Neurotransmitter XL
A comprehensive map of stress biology, neurotransmitters, and tryptophan metabolism
Neurotransmitter XL is a broad, functional assessment of the brain–body chemical messengers that shape mood, focus, sleep, energy, and resilience to stress. The panel investigates more than 30 biomarkers that span classic neurotransmitters (dopamine, noradrenaline, adrenaline, serotonin), inhibitory/excitatory balance (GABA and glutamate), the tryptophan–kynurenine pathway, catecholamine metabolism, key enzyme activities, essential cofactors (B vitamins, SAM, BH4), and objective markers linked to mitochondrial function and nitrosative stress.
Modern life exposes many people to persistent stressors—performance pressure, family or relationship challenges, uncertainty around work or finances. These factors engage neuroendocrine stress axes that raise cortisol and catecholamines. Over time, chronic stress can deplete neurotransmitters and strain cellular energy production, contributing to low mood, fatigue, sleep disruption, brain fog, and “burnout.” The Neurotransmitter XL panel is designed to identify such stress-related shifts early and to illuminate targeted, evidence-informed next steps with your clinician.
What this test measures
Core neurotransmitters
-
Dopamine, Noradrenaline (Norepinephrine), Adrenaline (Epinephrine)
Synthesized from tyrosine via L-DOPA, these catecholamines influence attention, motivation, cardiovascular tone, and the acute stress response. The panel also evaluates how efficiently these signals are inactivated (e.g., via COMT and MAO), offering context for sustained stress arousal patterns. -
Serotonin
An inhibitory neurotransmitter derived from tryptophan that supports mood stability, calm, sleep, and gut function; it also serves as a precursor to melatonin. -
GABA and Glutamate
GABA is the primary inhibitory neurotransmitter; glutamate is the primary excitatory neurotransmitter. Their balance is central to mental clarity, learning, emotional steadiness, and stress modulation.
Tryptophan and the kynurenine pathway
The panel goes beyond serotonin to assess tryptophan metabolism end-to-end. Under inflammatory or stress conditions, tryptophan is increasingly shunted from serotonin production toward kynurenine and downstream metabolites (e.g., quinolinic acid). This shift can:
-
Reduce serotonin availability (with possible effects on mood and sleep).
-
Increase neurotoxic and pro-oxidative compounds.
-
Impair cellular energy by lowering NAD generation, with downstream effects on mitochondrial ATP output.
By profiling kynurenine-pathway activity and related enzymes (e.g., IDO, KMO), the test clarifies whether stress and immune activation are redirecting tryptophan away from serotonin.
Catecholamine metabolism and enzyme context
Patterns in catecholamines are interpreted alongside enzyme-related breakdown routes (COMT → metanephrines; MAO → VMA). Persistently elevated values after lifestyle factors are addressed may prompt clinicians to consider enzyme capacity or genetic variants (e.g., COMT polymorphisms) that can slow clearance.
Cofactors that enable healthy neurotransmission
Neurotransmitter synthesis and breakdown require adequate cofactors:
-
B-vitamins: B6 (pyridoxal-5-phosphate), B12, folate;
-
Vitamin C, magnesium, and copper in specific steps;
-
Niacin (Vitamin B3) / NAD status for energy metabolism and pathway regulation;
-
SAM (S-adenosyl-methionine) for methylation-dependent reactions;
-
BH4 (tetrahydrobiopterin) as a critical cofactor in serotonin and catecholamine synthesis.
Where appropriate, the panel uses functional markers (e.g., methylmalonic acid for B12; cystathionine for B6 sufficiency; NAD and niacin species) to help identify bottlenecks that can block synthesis or skew pathways.
Mitochondrial and nitrosative stress markers
Because stress biology intersects with cellular energy, the profile includes organic acids and related indicators that can hint at:
-
Reduced pyruvate flux into the TCA cycle or compensatory lactate build-up;
-
Beta-oxidation constraints or L-carnitine insufficiency (e.g., suberic acid patterns);
-
Nitrosative stress signatures (e.g., citrulline with mitochondrial context like citrate).
These data help differentiate “neurotransmitter depletion” from mitochondrial-driven low energy, which may feel similar but arise from different root causes.
Immune activation and gut-derived signals
-
Neopterin can reflect TH1-type immune activation (e.g., IFN-γ-linked states) that often upregulate IDO/KMO, pushing tryptophan away from serotonin.
-
TMAO context connects dietary precursors (choline, betaine, L-carnitine), microbiome activity, inflammation risk, and the need to avoid over- or under-supplying key nutrients that are also essential for neurotransmission and membrane integrity.
Why this matters
-
Chronic stress re-wires biochemistry. Long-standing anxiety and overload can deplete neurotransmitters, alter tryptophan fate, and suppress mitochondrial ATP output, driving exhaustion.
-
Symptoms overlap but causes differ. Low mood, poor sleep, and fatigue can stem from neurotransmitter deficits, impaired methylation, micronutrient shortfalls, immune activation, or mitochondrial bottlenecks.
-
Actionable patterns. By pairing neurotransmitters with pathway enzymes, cofactors, and energy markers, clinicians can design targeted, staged care plans that address the right leverage points.
Who may consider Neurotransmitter XL
-
Individuals with persistent stress, burnout, low mood, anxiety, sleep problems, brain fog, headaches, or fluctuating energy.
-
Patients and clinicians exploring the biochemical links among mood, stress physiology, immunity, and cellular energy.
-
Cases where prior testing of a single neurotransmitter gave incomplete or conflicting clues.
Note: This is an advanced panel. Optimal value comes from interpretation by clinicians trained in neurochemistry, metabolism, and functional medicine.
What’s included (high-level)
-
Neurotransmitters: Dopamine, Noradrenaline, Adrenaline, Serotonin, GABA, Glutamate
-
Tryptophan–Kynurenine Pathway: Tryptophan, Kynurenine, pathway metabolites (e.g., quinolinic acid), and enzyme-activity context (IDO, KMO)
-
Catecholamine metabolism: Breakdown products and COMT/MAO pathway context
-
Cofactor status (functional context): B6, B12, folate, Vitamin C, Niacin/Nicotinamide/NAD, SAM/methylation balance, BH4 context
-
Mitochondrial and nitrosative stress context: Pyruvate, lactate, citrate, select dicarboxylic acids (e.g., suberic acid), citrulline
-
Immune activation and microbiome-linked markers: Neopterin, TMAO context
(Exact marker lists can vary by region and laboratory updates. Refer to your report for the complete analyte panel.)
Sample type and process
-
At-home urine collection (typically first-morning specimen, per kit instructions)
-
Prepaid return to the laboratory
-
Secure digital results
Interpreting common patterns (examples)
-
High adrenaline/noradrenaline with stress symptoms may reflect autonomic overload; interpretation considers clearance capacity (COMT/MAO routes), nutrient cofactors, and blood pressure or glycemic triggers.
-
Low serotonin with high kynurenine-to-tryptophan ratio suggests stress/inflammation-driven diversion away from serotonin toward kynurenine metabolites; clinicians often review inflammatory load, sleep, and cofactor sufficiency (B6, folate, B3/NAD).
-
GABA–glutamate imbalance can manifest as restlessness, overexcitability, or cognitive fatigue; evaluation looks at inhibitory tone versus excitatory drive and the role of sleep, stress, and nutrients.
-
Mitochondrial strain signatures (e.g., altered pyruvate/lactate; elevated suberic acid) can track with low energy despite adequate sleep and nutrition, guiding attention to mitochondrial supports and workload modulation.
-
Neopterin elevation points clinicians to immune activation that often correlates with IDO/KMO shifts and reduced serotonin availability.
These patterns are illustrative; clinical decisions depend on your complete history, medications, diet, and goals.
Important notes and safety
-
This test is intended for professional interpretation by doctors, clinics, or licensed therapists.
-
Do not change medications or start targeted supplements without clinical guidance—especially if you take agents that affect serotonin or catecholamines.
-
Dosages and treatment examples mentioned in laboratory literature are for clinician use and may not apply to your case.
Biomarkers in this category
34 biomarkers · optimal ranges shown
Betaine, also known as trimethylglycine (TMG), is a naturally occurring nutrient derived primarily from choline and found abundantly in foods such as beets, spinach, and whole grains. It serves as a key methyl donor in the body, supporting the conversion of homocysteine to methionine via the betaine-homocysteine methyltransferase (BHMT) pathway. This makes betaine a crucial participant in the body’s methylation network, working in parallel with folate, vitamin B12, and S-adenosylmethionine (SAM) to maintain cellular, neurological, and cardiovascular health. On the Neurotransmitter XL panel, betaine reflects methylation reserve capacity and the body’s ability to sustain healthy homocysteine metabolism, neurotransmitter regulation, and detoxification processes. Because methylation underlies the production and breakdown of key brain chemicals—including dopamine, serotonin, and adrenaline—betaine is deeply connected to mood, energy, focus, and stress resilience.
Choline is an essential nutrient that plays a foundational role in brain health, liver function, methylation, and neurotransmitter synthesis. It serves as both a structural building block for cell membranes and a biochemical precursor for several key molecules, including acetylcholine (a neurotransmitter critical for memory, focus, and muscle control) and betaine (trimethylglycine), a major methyl donor in the body. On the Neurotransmitter XL panel, choline reflects the body’s capacity to maintain membrane integrity, neurotransmitter balance, and methylation efficiency. Adequate choline ensures optimal communication between neurons, healthy liver metabolism, and efficient detoxification through the methionine cycle, which depends on methyl donors for proper function. Because the brain and liver are among the most metabolically active organs, choline status is often a key indicator of both cognitive performance and cellular energy balance.
Citrate is a key organic acid and an essential intermediate in the citric acid (Krebs) cycle, the core metabolic pathway responsible for producing energy (ATP) within the mitochondria. On the Neurotransmitter XL panel, citrate is used as a functional marker of mitochondrial health and oxidative metabolism, reflecting how efficiently the body converts nutrients into usable cellular energy. Because mitochondrial energy generation directly supports neurotransmitter synthesis, stress resilience, and detoxification, citrate levels can provide crucial insight into whether energy metabolism is functioning optimally—or if it’s being impaired by oxidative stress, inflammation, or nutrient deficiencies.
Dopamine is a key neurotransmitter involved in motivation, focus, movement, and emotional balance. On the Neurotransmitter XL panel, it’s measured alongside related catecholamines and cofactors to provide a complete view of the body’s stress and reward chemistry. Synthesized from tyrosine and dependent on nutrients like vitamin B6, iron, BH4, and magnesium, dopamine plays a vital role in both brain and autonomic function. The test evaluates dopamine production, breakdown (via COMT and MAO enzymes), and metabolic context, including methylation capacity (SAM/SAH ratio) and mitochondrial energy markers. Interpreted in combination with noradrenaline, serotonin, GABA, glutamate, and tryptophan metabolites, dopamine results help clarify whether mood and energy issues stem from neurotransmitter depletion, stress-related overactivity, or cofactor deficiencies. This biomarker provides essential insight into how the body regulates drive, alertness, and emotional resilience.
Kynurenine is a central metabolite in the tryptophan degradation pathway, known as the kynurenine pathway, which plays a vital role in neurotransmitter balance, immune regulation, mitochondrial energy production, and oxidative stress control. It sits at a critical metabolic crossroads—linking the amino acid tryptophan with the synthesis of nicotinamide adenine dinucleotide (NAD+), a molecule essential for cellular energy and redox balance. On the Neurotransmitter XL panel, kynurenine helps reveal whether tryptophan is being converted primarily into serotonin and melatonin (supporting mood and sleep) or diverted into stress- and inflammation-related pathways that generate neuroactive metabolites like quinolinic acid and kynurenic acid. Imbalances in kynurenine metabolism are often associated with chronic stress, immune activation, depression, fatigue, and mitochondrial dysfunction.
Nicotinamide adenine dinucleotide (NAD+) is a vital coenzyme present in every cell of the body. It plays a central role in energy production, redox balance, DNA repair, and cellular signaling. On the Neurotransmitter XL panel, NAD+ serves as a critical marker linking tryptophan metabolism, mitochondrial efficiency, and the body’s stress–energy balance. Derived from both dietary niacin (vitamin B3) and tryptophan metabolism via the kynurenine pathway, NAD+ acts as an electron carrier in oxidative reactions. It cycles between its oxidized (NAD+) and reduced (NADH) forms to drive ATP generation in mitochondria. Because it is also essential for enzymes involved in gene expression (sirtuins), detoxification, and neurotransmitter balance, its availability profoundly influences mental clarity, resilience, and metabolic vitality. Low NAD+ levels, as detected on this panel, can indicate mitochondrial dysfunction, oxidative stress, inflammation, or nutrient deficiency, while elevated NAD+ may reflect enhanced redox turnover or increased cellular demand under stress or repair processes.
Phenylalanine is an essential aromatic amino acid that serves as the biochemical starting point for several critical compounds in the body, including the catecholamine neurotransmitters — dopamine, noradrenaline, and adrenaline. On the Neurotransmitter XL panel, phenylalanine provides valuable insight into neurotransmitter synthesis capacity, stress metabolism, and amino acid balance. Because the body cannot produce phenylalanine, it must be obtained from dietary protein sources such as meat, eggs, fish, dairy, soy, and legumes. Once absorbed, phenylalanine is converted into tyrosine via the enzyme phenylalanine hydroxylase (PAH), a process dependent on the essential cofactor tetrahydrobiopterin (BH4), as well as iron and vitamin B6. Tyrosine then serves as the substrate for dopamine synthesis, which can subsequently be converted into noradrenaline and adrenaline. Thus, phenylalanine is the first building block in the catecholamine biosynthetic chain, influencing motivation, alertness, focus, stress resilience, and energy.
Quinolinic acid is a key intermediate in the kynurenine pathway, the primary route by which the amino acid tryptophan is metabolized into nicotinamide adenine dinucleotide (NAD+)—a molecule essential for cellular energy, mitochondrial function, and redox balance. Although it plays an important physiological role as a precursor for NAD+ synthesis, quinolinic acid can become neurotoxic when produced in excess, contributing to oxidative stress, inflammation, and excitatory neurochemical imbalances. On the Neurotransmitter XL panel, quinolinic acid serves as a sensitive biomarker of chronic stress, immune activation, mitochondrial dysfunction, and neuroinflammation. When tryptophan metabolism is shifted toward the kynurenine pathway—typically by inflammation or cortisol—quinolinic acid levels may rise. This metabolite’s dual nature makes it both vital and potentially harmful: necessary for energy metabolism but detrimental when uncontrolled.
S-Adenosylmethionine (SAM)—also known as SAMe—is a vital methyl donor molecule that supports hundreds of biochemical reactions throughout the body. Formed from the amino acid methionine and ATP, SAM plays an essential role in methylation, the process of transferring methyl groups (-CH3) to other molecules. This seemingly small chemical action regulates gene expression, neurotransmitter balance, detoxification, energy metabolism, and cell membrane integrity. On the Neurotransmitter XL panel, SAM is a key marker for assessing methylation capacity, neurotransmitter metabolism, and cellular energy regulation. Balanced SAM levels ensure efficient breakdown and recycling of neurotransmitters like dopamine, noradrenaline, and adrenaline, as well as proper support of the BH4 (tetrahydrobiopterin) cycle—an essential cofactor system for serotonin and catecholamine synthesis.
The SAM/SAH Ratio is one of the most powerful functional indicators of methylation efficiency in the human body. It represents the balance between S-Adenosylmethionine (SAM)—the body’s primary methyl donor—and S-Adenosylhomocysteine (SAH)—a byproduct that accumulates when methylation reactions slow down. On the Neurotransmitter XL panel, this ratio provides deep insight into the methylation cycle’s performance, influencing neurotransmitter metabolism, detoxification, DNA regulation, hormone balance, and energy production. A high SAM/SAH ratio reflects robust methylation activity, whereas a low ratio signals methylation inefficiency, often tied to nutrient deficiency, oxidative stress, or metabolic slowdown. This marker functions as a metabolic checkpoint—showing whether the body is efficiently transferring methyl groups (-CH3) to sustain biochemical reactions essential for mental health, energy, and cellular repair.
Serotonin (5-hydroxytryptamine, or 5-HT) is one of the body’s most important inhibitory neurotransmitters, involved in mood regulation, emotional stability, sleep, pain perception, digestion, and immune function. Although it is often called the “feel-good” neurotransmitter, serotonin’s role extends far beyond mental health — influencing nearly every system in the body. In the central nervous system (CNS), serotonin promotes calmness, emotional balance, and healthy sleep–wake rhythms. In the peripheral system, about 90% of serotonin is produced in the gastrointestinal tract, where it supports gut motility, blood clotting, and immune signaling. Serotonin is synthesized from the amino acid tryptophan, through two enzymatic steps: Tryptophan → 5-HTP (5-hydroxytryptophan) via tryptophan hydroxylase (requires iron, oxygen, and tetrahydrobiopterin (BH4)). 5-HTP → Serotonin via aromatic L-amino acid decarboxylase (AADC) (requires vitamin B6). Because serotonin synthesis depends on dietary tryptophan and key cofactors, any nutritional deficiency, inflammation, or stress-induced shift in metabolism can disrupt this pathway.
Tryptophan is an essential amino acid and the biochemical foundation for serotonin, melatonin, and NAD+ production, linking mood regulation, sleep, immune function, and energy metabolism. On the Neurotransmitter XL panel, it provides insight into how effectively the body converts nutrients into neurotransmitters and cellular energy. Low tryptophan levels—or diversion of tryptophan toward the kynurenine pathway during stress or inflammation—can lead to reduced serotonin and melatonin, resulting in low mood, fatigue, and poor sleep, while also generating neurotoxic metabolites that impair mitochondrial function. Because its metabolism depends on cofactors such as vitamin B6, folate, B12, niacin, iron, and BH4, deficiencies or chronic stress can disrupt tryptophan’s conversion pathways. Interpreted alongside serotonin, kynurenine, NAD+, and neopterin, tryptophan levels offer a window into the biochemical balance between emotional health, inflammation, and mitochondrial energy efficiency.
Tyrosine is a non-essential amino acid derived from phenylalanine, and it plays a pivotal role in the body’s ability to generate catecholamine neurotransmitters — dopamine, noradrenaline, and adrenaline. These compounds regulate motivation, alertness, attention, and stress response, making tyrosine a critical link between dietary amino acid balance and neurotransmitter function. On the Neurotransmitter XL panel, tyrosine serves as a key marker for assessing catecholamine precursor availability, stress metabolism, and neurotransmitter synthesis capacity. Low or high tyrosine levels can indicate issues with phenylalanine conversion, cofactor status, or metabolic demand from chronic stress and inflammation.